Indegene Limited (NSE:INDGN)
India · Delayed Price · Currency is INR 514.60
-0.10 (-0.02%)
Jul 31, 2026, 3:30 PM IST
Indegene Revenue
Indegene had revenue of 10.63B INR in the quarter ending June 30, 2026, with 39.73% growth. This brings the company's revenue in the last twelve months to 38.13B, up 30.41% year-over-year. In the fiscal year ending March 31, 2026, Indegene had annual revenue of 35.11B with 23.64% growth.
Revenue (ttm)
38.13B
Revenue Growth
+30.41%
P/S Ratio
3.25
Revenue / Employee
8.13M
Employees
4,687
Market Cap
124.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 35.11B | 6.71B | 23.64% |
| Mar 31, 2025 | 28.39B | 2.50B | 9.64% |
| Mar 31, 2024 | 25.90B | 2.84B | 12.29% |
| Mar 31, 2023 | 23.06B | 6.41B | 38.54% |
| Mar 31, 2022 | 16.65B | 6.84B | 69.76% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 112.30B |
| Marksans Pharma | 29.51B |
| Alivus Life Sciences | 25.90B |
| Park Medi World | 16.79B |
| Metropolis Healthcare | 16.46B |
Indegene News
- 2 days ago - Indegene Transcript: Q1 26/27 - Transcripts
- 2 days ago - Indegene Quarterly report: Q1 2027 - Filings
- 2 days ago - Indegene Slides: Q1 2027 - Filings
- 2 months ago - Indegene Slides: Investor presentation - Filings
- 3 months ago - Indegene Transcript: Q4 25/26 - Transcripts
- 3 months ago - Indegene Quarterly report: Q4 2026 - Filings
- 3 months ago - Indegene Slides: Q4 2026 - Filings
- 3 months ago - Indegene Annual report: Q4 2026 - Filings